Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)

Completed · Phase 2/Phase 3

Conditions studied: Influenza

In brief

This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 S-OIV (swine flu) vaccine in healthy young children.

Key facts

Study ID
NCT00972816
Run by
Novartis Vaccines
People needed
1357
Starts
2009-09-01
Expected to finish
2010-10-01
Last updated by the study team
2016-04-14

Who can join

Age: 3 and older, up to 8. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.